LXR inverse agonists inhibit de novo lipogenesis and reduce...

LXR inverse agonists inhibit de novo lipogenesis and reduce intestinal lipid and cholesterol absorption in a NAFLD mouse model

Kremoser, C., Deuschle, U., Gege, C., Kinzel, O., Krol, H.D., Albers, M., Birkel, M., Hambruch, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(18)30929-2
Date:
April, 2018
File:
PDF, 179 KB
english, 2018
Conversion to is in progress
Conversion to is failed